20 October 2017
Brussels
Reporter: Barney Dixon

European Commission to discuss SPCs


The European Commission will hear opinions on supplementary protection certificates (SPCs) and patent research exemptions as part of a new consultation that could impact biosimilars in the EU.

SPCs are an intellectual property right that currently offers innovative pharmaceutical and plant protection products the ability to extend the term of their patent rights by up to five years.

This offsets the loss of effective patent protection during compulsory clinical trials that are required before regulatory marketing approval.

The commission explained that the consultation was part of the EU’s Single Market Strategy, adopted in 2015.

In 2015, the commission said it would “consult, consider and propose further measures, as appropriate, to improve the patent system in Europe, notably for pharmaceutical and other industries whose products are subject to regulated market authorisations”.

The consultation will “explore a recalibration of certain aspects of patent and SPCs”, and could result in the creation of a European SPC title, an update of the scope of EU patent research exemptions and the introduction of an SPC manufacturing waiver.

The commission will also discuss the ‘Bolar’ patent exemption, which is used to speed up entry of generic products to the market by providing exemptions to patent protection, including SPCs.

Commenting on the consultation, Danish law firm Bech-Bruun, stated: “Bech-Bruun is excited to see the EU Commission’s efforts to clarify the highly complex legal area involving all parties concerned.”

It said: “Many years’ uncertainty across the EU has unreasonably enhanced the business risk of the pharmaceutical industry. Hopefully, the thorough analysis—supported by insights from the consultation process —will lead to an improvement of the patent and SPC regimes to the benefit of life sciences businesses and the health of EU citizens.”

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Baker Botts promotes three in IP
21 November 2017 | Texas | Reporter: Barney Dixon
Baker Botts has promoted three intellectual property attorneys to partner, as part of a round of 11 partner promotions
Alibaba in ITC spotlight
20 November 2017 | Washington DC | Reporter: Barney Dixon
Alibaba will be investigated by the US International Trade Commission over the importation and sale of insulated beverage containers, their labels, and packaging materials
MediaTek partners with Anaqua
20 November 2017 | Boston | Reporter: Barney Dixon
Taiwanese semiconductor company MediaTek has selected Anaqua to manage its intellectual property activities, including its inventions and patents
Brazil and China sign PPH agreement
17 November 2017 | Beijing | Reporter: Barney Dixon
The State Intellectual Property Office of China has signed a patent prosecution highway agreement with the Brazilian National Institution of Intellectual Property
Cozen O’Connor hires ex-DLA Piper litigator
17 November 2017 | Washington DC | Reporter: Barney Dixon
Cozen O’Connor has hired ex-DLA Piper litigator Hugh Marbury as member in its intellectual property department
Mewburn Ellis opens Munich office
16 November 2017 | Munich | Reporter: Barney Dixon
Intellectual property boutique Mewburn Ellis has opened a new office in Munich, its first expansion outside of the UK
EPO faces backlash over scrapping of permanent employment contracts
15 November 2017 | Munich | Reporter: Barney Dixon
In an internal memo, the Staff Union of the European Patent Office described the move as “Kafkaesque”